MedCity News
SEPTEMBER 9, 2022
Acquiring Shine will help Headspace Health improve its diversity, equity, inclusion and belonging efforts. Shine was first created in 2016 to provide mental health support to those in marginalized communities.
PharmExec
SEPTEMBER 9, 2022
Tracking the pandemic’s influence on brand awareness and prescribing efforts in light of decline in physician visits and fewer diagnoses—and what these dynamics, still unsettled post-pandemic, might mean for future launches.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
SEPTEMBER 9, 2022
Trilliant Health created a new AI-powered index for comparative hospital benchmarking. Healthcare stakeholders across the entire industry — including hospitals, payers, device companies, drugmakers and tech vendors — can use the tool to inform their strategies for things like competitive analysis, clinical quality program management, mergers, acquisitions and product sales.
Pharmaceutical Technology
SEPTEMBER 9, 2022
US-based biotech company Gatehouse Bio is extending its collaboration with AstraZeneca for developing RNA therapeutics to treat heart failure with preserved ejection fraction (HFpEF). Initially, the companies partnered to identify new targets for respiratory and cardiovascular diseases using Gatehouse Bio’s artificial intelligence (AI)-powered platform in December 2019.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
SEPTEMBER 9, 2022
Claim.MD is an electronic data interchange clearinghouse that helps reduce claims denials and improve cash flow. By working with the company, Walgreens has been able to make its reimbursement process more efficient and grow its business.
pharmaphorum
SEPTEMBER 9, 2022
Digital health specialist Kry has teamed up with pharma group Novo Nordisk on the development of resources that can help people with obesity manage their condition and adhere to treatment. The partners anticipate that the digital obesity programme will launch later this autumn in Sweden, ahead of a broader rollout in other European markets before the end of the year.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
SEPTEMBER 9, 2022
The pandemic forced clinical trial sponsors to change their processes, with a more technology-driven approach and, according to a new study by Medidata, the sector is now “stronger than ever” as a result. The study , based on interviews conducted earlier this year with 400 clinical trial executives from the UK, France, Germany, and Switzerland, found that more than a third (37%) ranked better outcomes of trials within the top three areas of improvement since COVID-19 emerged.
MedCity News
SEPTEMBER 9, 2022
The judge’s ruling mentioned the Supreme Court decision in Burwell v. Hobby Lobby multiple times, which said that the chain of stores did not have to cover contraception since it violated the RFRA. .
pharmaphorum
SEPTEMBER 9, 2022
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth. Pharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. But preparing to adapt to the phenomenon presents an opportunity as well as a challenge.
MedCity News
SEPTEMBER 9, 2022
Derra Howard, founder and patient advocate for Saving Grace Epilepsy Foundation, will be part of a panel on navigating the financial journey in healthcare at INVEST Digital Health in Dallas on September 28. Register today!
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmExec
SEPTEMBER 9, 2022
A fresh look at how industry benchmarks can help fortify new drug launches to overcome today’s new market-entry barriers and higher expectations.
MedCity News
SEPTEMBER 9, 2022
Panelists at a session on diagnostics at MedtechVision 2022, a hybrid conference organized by MedtechWomen stressed that consumer and physician experience with a product is what is key in medtech innovation compared with simply adding bells and whistles.
PharmExec
SEPTEMBER 9, 2022
Use against pair of pathways could pave way for standout in stocked eye disease market.
MedCity News
SEPTEMBER 9, 2022
Strata Oncology partnered with UW Health to integrated its next generation sequencing tumor profiling test into the health system’s Epic EHR. Being able to order the test and see its results from within the EHR will help UW clinicians more efficiently leverage genomic findings into their precision oncology treatment plans.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
PharmExec
SEPTEMBER 9, 2022
Dual-targeted injection poised to rock GLP-1 field in diabetes—and eventually weight loss.
MedCity News
SEPTEMBER 9, 2022
This is the second Fast Track designation Anthos has received for abelacimab in less than two months. The therapeutic is also the first Factor XI inhibitor to start enrolling patients in Phase 3 trials.
PharmaTimes
SEPTEMBER 9, 2022
Company is introducing abiraterone film-coated tablets for treating metastatic prostate cancer
MedCity News
SEPTEMBER 9, 2022
Based in San Francisco, Allermi aims to create a national market for a customizable approach to allergy relief pioneered by a California doctor.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharmacy Times
SEPTEMBER 9, 2022
Prescription drug monitoring programs have decreased prescription opioids in the United States but resulted in unintended spikes of illegal drug use and heroin-related deaths.
MedCity News
SEPTEMBER 9, 2022
Check out new developments from Carrum Health, Springboard Enterprises, Bessemer Venture Partners, and more.
PharmaTimes
SEPTEMBER 9, 2022
Research showed significant improvements in signs and symptoms of prurigo nodularis
Copyright Clearance Center
SEPTEMBER 9, 2022
The post “Is the publishing industry broken?” appeared first on Copyright Clearance Center.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Rep-Lite
SEPTEMBER 9, 2022
The employees of a business contribute to its success. Therefore, it is vital for companies, particularly in the medical and pharmaceutical industries, need to make sure that the best people get to work with them. When significant businesses offer sales jobs and other positions, the interview plays a substantial role in ensuring that you get suited employees.
PharmExec
SEPTEMBER 9, 2022
Pharm Exec catches up with longtime Merck international business leader Kevin Ali to find out how Organon, the ambitious Merck spinoff he formed just over a year ago, has fared so far in delivering on its mission of creating a global leader and difference-maker in women’s health.
Rep-Lite
SEPTEMBER 9, 2022
The employees of a business contribute to its success. Therefore, it is vital for companies, particularly in the medical and pharmaceutical industries, need to make sure that the best people get to work with them. When significant businesses offer sales jobs and other positions, the interview plays a substantial role in ensuring that you get suited employees.
PharmExec
SEPTEMBER 9, 2022
Senior leaders in pharma, healthcare marketing and communications, and advertising got together to discuss the progress and lingering roadblocks in advancing diversity, equity, and inclusion strategies in the life sciences—where the common thread seems clear: the messenger matters.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
pharmaphorum
SEPTEMBER 9, 2022
The experienced executive will expand our cross-functional omnichannel, data and analytics, and technology offerings, developing effective solutions to meet our clients’ evolving needs. Geoff Thorne has joined Fishawack Health (FH) as our new Chief Technology Officer. He will focus on refining our technology and strategy offerings to solve complex challenges for our biopharmaceutical, medical technology, and wellness clients.
PharmaTimes
SEPTEMBER 9, 2022
Get started on your entry for these prestigious awards now – the deadline is 16 September 2022
pharmaphorum
SEPTEMBER 9, 2022
A higher dose of Regeneron and Bayer’s Eylea given every three or four months has shown efficacy in a pair of clinical trials, in a big boost for the multibillion-dollar product. The two studies – in wet age-related macular degeneration (AMD) and diabetic macular oedema (DME) – showed the 12- and 16-week Eylea (aflibercept) regimens were non-inferior to the currently approved 8-week dosing, reducing the number of injections into the eye needed by patients with the sight-robbing diseases.
PharmaTech
SEPTEMBER 9, 2022
FDA is in jeopardy of losing its fees for assessing and approving new drugs and medical products.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
110 
Let's personalize your content